Research on drug-drug interaction (DDI) prediction, particularly in identifying DDI event types, is crucial for understanding adverse drug reactions and drug combinations. This work introduces a Bidirectional Recurrent Neural Network model for DDI event type prediction (BiRNN-DDI), which simultaneously considers structural relationships and contextual information. Our BiRNN-DDI model constructs drug feature graphs to mine structural relationships. For contextual information, it transforms drug graphs into sequences and employs a two-channel structure, integrating BiRNN, to obtain contextual representations of drug-drug pairs. The model’s effectiveness is demonstrated through comparisons with state-of-the-art models on two DDI event-type benchmarks. Extensive experimental results reveal that BiRNN-DDI surpasses other models in accuracy, AUPR, AUC, F1 score, Precision, and Recall metrics on both small and large datasets. Additionally, our model exhibits a lower parameter space, indicating more efficient learning of drug feature representations and prediction of potential DDI event types.
Get full access to this article
View all access options for this article.
References
1.
Al-RabeahMH, LakizadehA. Prediction of drug-drug interaction events using graph neural networks based feature extraction. Sci Rep, 2022; 12(1).
2.
BagherianM, SabetiE, WangK, et al.Machine learning approaches and databases for prediction of drug–target interaction: A survey paper. Brief Bioinform, 2021; 22(1):247–269.
3.
BaiT, LiC, PengX, et al.A Novel Drug-Drug Interaction Prediction Model Based on Line Subgraph Generation Strategy. In: 2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) IEEE; 2023; pp. 153–158.
4.
BonginiP, ScarselliF, BianchiniM, et al.Modular multi–source prediction of drug side–effects with DruGNN. IEEE/ACM Trans Comput Biol Bioinform, 2023; 20(2):1211–1220.
5.
BrownJD, WintersteinAG. Potential adverse drug events and drug–drug interactions with medical and consumer cannabidiol (CBD) use. J Clin Med, 2019; 8(7):989.
6.
CaoC, KossinnaP, KwokD, et al.Disentangling genetic feature selection and aggregation in transcriptome-wide association studies. Genetics, 2022; 220(2):iyab216.
7.
CaoC, KwokD, EdieS, et al.kTWAS: Integrating kernel machine with transcriptome-wide association studies improves statistical power and reveals novel genes. Brief Bioinform, 2021; 22(4):bbaa270.
8.
ChenY, MaT, YangX, et al.MUFFIN: Multi-scale feature fusion for drug–drug interaction prediction. Bioinformatics, 2021; 37(17):2651–2658.
9.
ChengF, KovácsIA, BarabásiA-L. Network-based prediction of drug combinations. Nat Commun, 2019; 10(1):1197.
10.
DaiY, GuoC, GuoW, et al.Drug–drug interaction prediction with Wasserstein adversarial autoencoder-based knowledge graph embeddings. Brief Bioinform, 2021; 22(4):bbaa256.
11.
DasP, MazumderDH. An extensive survey on the use of supervised machine learning techniques in the past two decades for prediction of drug side effects. Artif Intell Rev, 2023:1–28.
12.
DengY, XuX, QiuY, et al.A multimodal deep learning framework for predicting drug–drug interaction events. Bioinformatics, 2020; 36(15):4316–4322.
13.
DingY, GuoF, TiwariP, et al.Identification of drug-side effect association via multi-view semi-supervised sparse model. IEEE Trans Artif Intell, 2023a;5(5):2151–2162.
14.
DingY, TangJ, GuoF. Identification of Drug-Side Effect Association via Semisupervised Model and Multiple Kernel Learning. IEEE J Biomed Health Inform, 2019; 23(6):2619–2632.
15.
DingY, TiwariP, GuoF, et al.Multi-correntropy fusion based fuzzy system for predicting DNA N4-methylcytosine sites. Inf Fusion, 2023b;100:101911.
16.
DouM, HanH, ChenG, et al.BP-DDI: Drug-drug interaction prediction based on biological information and pharmacological text. IEEE Int Conf Bioinform Biomed (BIBM); 2022; pp. 410–415.
17.
DouM, TangJ, TiwariP, et al.Drug-drug interaction relation extraction based on deep learning: A review. ACM Comput Surv, 2024.
18.
FengYH, ZhangSW. Prediction of drug-drug interaction using an attention-based graph neural network on drug molecular graphs. Molecules, 2022; 27(9):3004.
19.
GuoL, LeiX, ChenM, et al.MSResG: Using GAE and residual GCN to predict drug–drug interactions based on multi-source drug features. Interdiscip Sci Comput Life Sci, 2023; 15(2):171–188.
20.
HanCD, WangCC, HuangL, et al.MCFF-MTDDI: Multi-channel feature fusion for multi-typed drug-drug interaction prediction. Brief Bioinform, 2023; 24(4):bbad215.
21.
HanX, XieR, LiX, et al.SmileGNN: Drug-drug interaction prediction based on the SMILES and graph neural network. Life, 2022; 12(2):319.
22.
HeH, ChenG, Yu-Chian ChenC. 3DGT-DDI: 3D graph and text based neural network for drug–drug interaction prediction. Brief Bioinform, 2022; 23(3):bbac134.
23.
HuangA, XieX, YaoX, et al.HF-DDI: Predicting drug–drug interaction events based on multimodal hybrid fusion. J Comput Biol, 2023; 30(9):961–971.
24.
JaradaTN, RokneJG, AlhajjR. A review of computational drug repositioning: Strategies, approaches, opportunities, challenges, and directions. J Cheminform, 2020; 12(1):1–23.
25.
KastrinA, FerkP, LeskošekB. Predicting potential drug-drug interactions on topological and semantic similarity features using statistical learning. PLoS ONE, 2018; 13(5):e0196865.
26.
LeeG, ParkC, AhnJ. Novel deep learning model for more accurate prediction of drug-drug interaction effects. BMC Bioinformatics, 2019; 20(1):1–8.
27.
LiZ, ZhuS, ShaoB, et al.DSN-DDI: An accurate and generalized framework for drug–drug interaction prediction by dual-view representation learning. Brief Bioinform, 2023; 24(1):bbac597.
28.
LinS, ChenW, ChenG, et al.MDDI-SCL: Predicting multi-type drug-drug interactions via supervised contrastive learning. J Cheminform, 2022a;14(1):1–12.
29.
LinS, WangY, ZhangL, et al.MDF-SA-DDI: Predicting drug–drug interaction events based on multi-source drug fusion, multi-source feature fusion and transformer self-attention mechanism. Brief Bioinform, 2022b;23(1):bbab421.
30.
LinX, QuanZ, WangZJ, et al.KGNN: Knowledge graph neural network for drug-drug interaction prediction. In: IJCAI, vol. 380; 2020; pp. 2739–2745.
31.
LiuS, ZhangY, CuiY, et al.Predicting drug-drug interactions using multi-modal deep auto-encoders based network embedding and positive-unlabeled learning. Methods, 2020; 179:37–46.
32.
LiuS, ZhangY, CuiY, et al.Enhancing drug-drug interaction prediction using deep attention neural networks. IEEE/ACM Trans Comput Biol Bioinform, 2023; 20(2):976–985.
33.
MaM, LeiX. A dual graph neural network for drug–drug interactions prediction based on molecular structure and interactions. PLoS Comput Biol, 2023; 19(1):e1010812.
34.
MakKK, PichikaMR. Artificial intelligence in drug development: Present status and future prospects. Drug Discov Today, 2019; 24(3):773–780.
ParkC, ParkJ, ParkS. AGCN: Attention-based graph convolutional networks for drug-drug interaction extraction. Expert Syst Appl, 2020; 159:113538.
37.
QianY, DingY, ZouQ, et al.Identification of drug-side effect association via restricted Boltzmann machines with penalized term. Brief Bioinform, 2022; 23(6):bbac458.
38.
RyuJY, KimHU, LeeSY. Deep learning improves prediction of drug–drug and drug–food interactions. Proc Natl Acad Sci USA, 2018; 115(18):E4304–E4311.
39.
SachdevK, GuptaMK. A comprehensive review of computational techniques for the prediction of drug side effects. Drug Dev Res, 2020; 81(6):650–670.
40.
SuX, HuL, YouZ, et al.Attention-based knowledge graph representation learning for predicting drug-drug interactions. Brief Bioinform, 2022; 23(3):bbac140.
41.
VoTH, NguyenNTK, KhaQH, et al.On the road to explainable AI in drug-drug interactions prediction: A systematic review. Comput Struct Biotechnol J, 2022; 20:2112–2123.
42.
WangG, LouX, GuoF, et al.EHR-HGCN: An enhanced hybrid approach for text classification using heterogeneous graph convolutional networks in electronic health records. IEEE J Biomed Health Inform, 2023a;28(3):1668–1679.
43.
WangY, MinY, ChenX, et al.Multi-view Graph Contrastive Representation Learning for Drug-Drug Interaction Prediction. In: WWW’21: The Web Conference; 2021.
44.
WangY, ZhangX, JuY, et al.Identification of human microRNA-disease association via low-rank approximation-based link propagation and multiple kernel learning. Front Comput Sci, 2024; 18(2):182903.
45.
WangY, ZhangY, WangJ, et al.Prediction of drug-target interactions via neural tangent kernel extraction feature matrix factorization model. Comput Biol Med, 2023b;159:106955.
46.
WuH, LiuJ, JiangT, et al.AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism. Neural Netw, 2024; 169:623–636.
47.
XiongZ, LiuS, HuangF, et al.Multi-relational contrastive learning graph neural network for drug-drug interaction event prediction. In: Proceedings of the AAAI Conference on Artificial Intelligence; 2023; pp. 5339–5347.
48.
XuR, LuoL, LiuZ, et al.CLDDI: A Novel Method for Predicting Drug-Drug Interaction Events Based on Graph Contrastive Learning. In: 2023 11th International Conference on Bioinformatics and Computational Biology (ICBCB) IEEE; 2023; pp. 105–112.
49.
YangZ, TongK, JinS, et al.CNN-Siam: Multimodal siamese CNN-based deep learning approach for drug–drug interaction prediction. BMC Bioinformatics, 2023; 24(1):1–12.
50.
YuH, MaoKT, ShiJY, et al.Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization. BMC Syst Biol, 2018; 12(S1):101–110.
51.
ZhangC, LuY, ZangT. CNN-DDI: A learning-based method for predicting drug–drug interactions using convolution neural networks. BMC Bioinformatics, 2022; 23(S1):1–12.
52.
ZhangW, JingK, HuangF, et al.SFLLN: A sparse feature learning ensemble method with linear neighborhood regularization for predicting drug–drug interactions. Inf Sci, 2019; 497:189–201.
